Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.
about
Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@en
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@nl
type
label
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@en
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@nl
prefLabel
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@en
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@nl
P2093
P2860
P356
P1476
Extended trastuzumab therapy i ...... otherapy for brain metastases.
@en
P2093
Hidemitsu Nakagawa
Hideyuki Arita
Hitoshi Tsuda
Kan Yonemori
Motohiko Maruno
Soichiro Shibui
Takayuki Kinoshita
Tsuyoshi Suzuki
Yasuhiko Tomita
Yasuhiro Fujiwara
P2860
P304
P356
10.3892/MCO.2013.162
P577
2013-07-29T00:00:00Z